ClinicalTrials.gg
CompletedNCT07844499Updated Sep 28, 2026

Labor Characteristics and Maternal-Infant Outcomes in Preterm Primiparous Women

An observational study in Preterm Birth, sponsored by Maternal and Child Health Hospital, Jiading District. Completed at 1 site in China. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-09-28.

Sponsored by Maternal and Child Health Hospital, Jiading District · Observational

How we know

Updated Sep 28, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
436
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 79 studies in Premature Birth with a site in China — 26 open to participants now, 31 under way, 2 of them phase 3. Premature Birth · China.

Enrollment
19th of 35
436 · median 541
Started
2020
with 8 others
Observational
35 of 79
14 open now
Registered
79th of 79
by date

Among the 79 studies in Premature Birth with a site in China, this one is the 19th largest by enrollment of the 35 observational ones that give a count, is one of 9 that started in 2020, is one of 35 observational ones, and was the 79th registered.

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.

Browse Premature Birth studies →

Open to participants now

26 of the 79 studies in Premature Birth with a site in China are open now. Recruiting first, the newest first:

21 more — sign in →

All 26 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.

This study: 18 Years to 45 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 79 studies in Premature Birth with a site in China, or all of them as a file.
02

Study summary

This retrospective observational study evaluates labor characteristics in primiparous women with spontaneous preterm birth at different gestational ages and examines their associations with maternal and neonatal outcomes. Medical records of women who delivered at Shanghai Jiading District Maternity and Child Health Care Hospital between January 1, 2020, and December 31, 2025, are reviewed.

Participants are classified according to gestational age at delivery into very preterm (28 to 31+6 weeks), moderate preterm (32 to 33+6 weeks), and late preterm (34 to 36+6 weeks) groups. The study compares the onset and duration of the active phase of labor, cervical dilation rate, and durations of the first and second stages of labor across these gestational-age groups.

The study also evaluates the associations between labor duration and maternal and neonatal outcomes, including postpartum blood loss, mode of vaginal delivery, and 5-minute Apgar score. The findings are intended to provide evidence for gestational age-specific and individualized labor management in women with spontaneous preterm birth.

Read the detailed description

This is a single-center, retrospective observational study based on electronic medical records from Shanghai Jiading District Maternity and Child Health Care Hospital. The study population consists of primiparous women with spontaneous preterm birth at 28 to 36+6 weeks of gestation who delivered vaginally between January 1, 2020, and December 31, 2025.

Participants are categorized into three gestational-age groups: very preterm (28 to 31+6 weeks), moderate preterm (32 to 33+6 weeks), and late preterm (34 to 36+6 weeks). Labor characteristics assessed include cervical dilation at the onset of the active phase, duration of the active phase, mean cervical dilation rate during the active phase, duration of the first stage of labor, and duration of the second stage of labor. The study also evaluates differences in labor duration according to the use of epidural labor analgesia.

Maternal and neonatal variables collected from the medical records include maternal age, gravidity, pre-pregnancy body mass index, gestational age at delivery, pregnancy-related complications and comorbidities, neonatal birth weight, vaginal delivery status, postpartum blood loss within 2 hours after delivery, postpartum hemoglobin level, and 5-minute Apgar score.

Associations between the durations of the first and second stages of labor and maternal or neonatal outcomes are evaluated using regression analyses with adjustment for relevant potential confounding variables. Linear regression is used to assess postpartum blood loss, multinomial logistic regression is used to evaluate vaginal delivery outcomes, and binary logistic regression is used to evaluate neonatal Apgar outcomes. Restricted cubic spline analyses are used to explore potential dose-response relationships between labor duration and outcomes showing statistically significant associations.

The study is non-interventional. All information is obtained retrospectively from existing medical records and is analyzed after de-identification.

03

Conditions studied

  • Preterm Birth

Browse trials for

Keywords

  • Spontaneous Preterm Birth
  • Primiparous Women
  • Gestational Age
  • Labor Duration
  • Active Phase of Labor
  • Cervical Dilation
  • First Stage of Labor
  • Second Stage of Labor
  • Maternal Outcomes
  • Neonatal Outcomes
  • Epidural Analgesia
  • Postpartum Blood Loss
  • Apgar Score
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Primiparous women with spontaneous preterm birth who delivered vaginally at Shanghai Jiading District Maternity and Child Health Care Hospital between January 1, 2020, and December 31, 2025, were identified retrospectively from the hospital electronic medical record system. Eligible women had a singleton pregnancy with vertex presentation and delivered between 28 weeks 0 days and 36 weeks 6 days of gestation. Participants were classified according to gestational age at delivery into very preterm, moderate preterm, and late preterm groups.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Primiparous women undergoing vaginal delivery.

  • Gestational age at delivery from 28 weeks 0 days to 36 weeks 6 days.
  • Spontaneous preterm labor.
  • Singleton pregnancy with vertex presentation.
  • No labor interventions such as administration of uterotonic agents for labor augmentation or artificial rupture of membranes during labor.
  • Complete clinical records.

Exclusion criteria

Exclusion Criteria:

  • Labor induction due to intrauterine fetal demise.
  • Twin or multiple pregnancy.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
436 participants (actual)
Patient registry
No

Groups and cohorts

  • Very Preterm Group

    Primiparous women with spontaneous preterm birth who delivered vaginally at 28 weeks 0 days to 31 weeks 6 days of gestation. This group included 45 participants. No study-specific intervention was assigned; clinical and labor data were retrospectively obtained from existing medical records.

    Other: Gestational Age at Delivery

  • Moderate Preterm Group

    Primiparous women with spontaneous preterm birth who delivered vaginally at 32 weeks 0 days to 33 weeks 6 days of gestation. This group included 37 participants. No study-specific intervention was assigned; clinical and labor data were retrospectively obtained from existing medical records.

    Other: Gestational Age at Delivery

  • Late Preterm Group

    Primiparous women with spontaneous preterm birth who delivered vaginally at 34 weeks 0 days to 36 weeks 6 days of gestation. This group included 354 participants. No study-specific intervention was assigned; clinical and labor data were retrospectively obtained from existing medical records.

    Other: Gestational Age at Delivery

Interventions

  • OtherGestational Age at Delivery

    Gestational age at delivery was the primary exposure of interest. Participants were retrospectively classified into three groups according to gestational age at delivery: very preterm (28 weeks 0 days to 31 weeks 6 days), moderate preterm (32 weeks 0 days to 33 weeks 6 days), and late preterm (34 weeks 0 days to 36 weeks 6 days). No study-specific intervention was assigned, and all exposure and outcome information was obtained from existing medical records.

06

What researchers measure

Primary outcomes

  1. Duration of the Active Phase of Labor

    Duration of the active phase of labor, measured in hours, from the onset of the active phase to full cervical dilation (10 cm). The onset of the active phase was defined as the cervical dilation corresponding to the inflection point at which the cervical dilation curve changed from a gradual slope to its maximum slope.

    Time frame: During labor, from the identified onset of the active phase to full cervical dilation (10 cm)

  2. Title Description Time Frame Cervical Dilation at the Onset of the Active Phase

    Cervical dilation, measured in centimeters, at the identified onset of the active phase of labor.

    Time frame: At onset of the active phase during the index delivery

  3. Mean Cervical Dilation Rate During the Active Phase

    Mean cervical dilation rate, measured in cm/hour, calculated as (10 cm minus cervical dilation at the onset of the active phase) divided by the duration of the active phase.

    Time frame: During labor, from the identified onset of the active phase to full cervical dilation (10 cm)

  4. Duration of the First Stage of Labor

    Duration of the first stage of labor, measured in hours, as documented in the obstetric medical record.

    Time frame: During labor, from the documented onset of labor to full cervical dilation (10 cm)

  5. Duration of the Second Stage of Labor

    Duration of the second stage of labor, measured in hours, from full cervical dilation to delivery of the fetus.

    Time frame: During labor, from full cervical dilation (10 cm) to fetal delivery

Secondary outcomes

  1. Postpartum Blood Loss Within 2 Hours After Delivery

    Postpartum blood loss within 2 hours after delivery, measured in milliliters using the gravimetric weighing method and documented in the medical record.

    Time frame: From fetal delivery through 2 hours postpartum

  2. Vaginal Delivery Status

    Vaginal delivery status categorized as spontaneous vaginal delivery, episiotomy, or forceps-assisted vaginal delivery, as documented in the medical record.

    Time frame: At the time of delivery

  3. 5-Minute Apgar Score

    Neonatal Apgar score assessed 5 minutes after birth and documented in the medical record. The score was evaluated to assess neonatal condition after delivery.

    Time frame: 5 minutes after birth

07

Study locations

1 site
  • Maternal and Child Health Hospital, Jiading District
    Shanghai, Shanghai Municipality 201821, China
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the reported study results may be shared with qualified researchers upon reasonable request to the corresponding author. The shared data may include relevant maternal characteristics, gestational age at delivery, labor characteristics, maternal outcomes, and neonatal outcomes. No directly identifiable participant information will be provided. Data sharing will be subject to institutional approval and applicable privacy and data protection requirements.

Supporting information: Study protocol

Time frame: Data will be available beginning after publication of the primary study results and will remain available in accordance with the institution's data retention and governance policies.

Access criteria: Qualified researchers may request access to the de-identified individual participant data from the corresponding author for legitimate scientific research purposes. Requests will be reviewed on a case-by-case basis by the study investigators and, where required, the institution. Access will be subject to institutional approval and applicable privacy, confidentiality, and data protection requirements.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2020 to primary completion in Dec 2025, 71 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 18, 2026
First posted
Sep 28, 2026
StartActual
Jan 1, 2020
Primary completionActual
Dec 31, 2025
CompletionActual
Dec 31, 2025
Last update
Sep 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 28, 2026
Show all 1 update
  1. Sep 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07844499
Lead sponsor
Maternal and Child Health Hospital, Jiading District
Responsible party
Li Wu (Principal Investigator, Maternal and Child Health Hospital, Jiading District) — Principal investigator
First posted
Sep 28, 2026
Start date
Jan 1, 2020
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025
Last update
Sep 28, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion